Molecular Trajectory of BRCA1 and BRCA2 Mutations

Area of Science:

• Genomic instability and cancer biology
• Molecular oncology
• Fanconi anemia pathway

Background:

• Cancer is characterized by genomic mutations, with some predisposition mutations present from germ cell genesis.
• BRCA1 and BRCA2 are key cancer predisposition genes linked to hereditary breast and ovarian cancer syndrome.
• Advances in molecular genetics highlight the importance of these genes in cancer prevention, diagnostics, and therapeutics.

Purpose of the Study:

• To review the molecular significance of BRCA1 and BRCA2 genes.
• To explore their history, function, interactions, and dysfunction.
• To discuss their role in mutational signatures and clinical oncology.

Main Methods:

• Literature review of BRCA1 and BRCA2 genes.
• Analysis of molecular functions and protein interactions.
• Examination of mutational signatures and genomic alterations.

Main Results:

• BRCA1 and BRCA2 are integral to the Fanconi anemia pathway.
• BRCA gene dysfunction influences the mutational processes in cancer cells.
• Comprehensive cancer genome analyses reveal insights into past mutational processes and future cancer behavior.

Conclusions:

• BRCA1 and BRCA2 mutations are principal targets in clinical molecular oncology.
• Understanding BRCA gene status aids in predicting cancer trajectory.
• Molecular insights into BRCA genes are vital for advancing cancer care.